Compare Amphastar Pharmaceuticals Inc (AMPH) vs Corsair Gaming Inc (CRSR) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Corsair Gaming (CRSR) trades at $9.66, up 1.15% with a bullish technical outlook. The stock shows mixed fundamentals with a high P/E ratio of 107.33 but attractive P/S of 0.71, while recent earnings beats and new AI product launches drive optimism. Revenue remains stable around $1.5B, though profitability is inconsistent with a net margin of just 0.49%.

Corsair presents a speculative opportunity with strong product innovation but faces execution risks. Analyst consensus is cautious with a $9 price target below current levels. The company's pivot to AI hardware and gaming partnerships offers growth potential, but thin margins and competitive pressures require careful monitoring for sustained profitability.